{"entity":{"type":"insider","cik":"0001870270","url":"/insider/0001870270","json_url":"/insider/0001870270.json","name":"Tari Leslie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2022-01-07","last":"2025-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Tari Leslie","source":"filing","n_filings":9,"first_seen":"2022-01-07","last_seen":"2025-03-13"}],"transactions":[{"id":4385012,"accession":"0001610618-25-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-25-000023","line_url":"/filing/0001610618-25-000023#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1773.0,"shares_display":"1,773","price_per_share":21.9626,"price_display":"21.96","price_state":"stated","total_value":38939.6898,"total_display":"38,939.69","total_whole":"38,940","shares_owned_after":16215.0,"shares_owned_after_display":"16,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":3186329,"accession":"0001610618-24-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-24-000123","line_url":"/filing/0001610618-24-000123#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":909.0,"shares_display":"909","price_per_share":11.6393,"price_display":"11.64","price_state":"stated","total_value":10580.1237,"total_display":"10,580.12","total_whole":"10,580","shares_owned_after":17788.0,"shares_owned_after_display":"17,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":3095449,"accession":"0001610618-24-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-24-000016","line_url":"/filing/0001610618-24-000016#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21029.0,"shares_display":"21,029","price_per_share":0.6698,"price_display":"0.67","price_state":"stated","total_value":14085.2242,"total_display":"14,085.22","total_whole":"14,085","shares_owned_after":258681.0,"shares_owned_after_display":"258,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":8563321,"accession":"0001610618-23-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-23-000090","line_url":"/filing/0001610618-23-000090#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18469.0,"shares_display":"18,469","price_per_share":0.948,"price_display":"0.95","price_state":"stated","total_value":17508.612,"total_display":"17,508.61","total_whole":"17,509","shares_owned_after":275710.0,"shares_owned_after_display":"275,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":8509624,"accession":"0001610618-23-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-23-000083","line_url":"/filing/0001610618-23-000083#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":9700.0,"total_display":"9,700.00","total_whole":"9,700","shares_owned_after":294179.0,"shares_owned_after_display":"294,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-14","scope":"insider"},{"id":8736981,"accession":"0001610618-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-23-000012","line_url":"/filing/0001610618-23-000012#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7562.0,"shares_display":"7,562","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":11569.86,"total_display":"11,569.86","total_whole":"11,570","shares_owned_after":190179.0,"shares_owned_after_display":"190,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-13","scope":"insider"},{"id":8024902,"accession":"0001610618-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-23-000003","line_url":"/filing/0001610618-23-000003#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11814.0,"shares_display":"11,814","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":14176.8,"total_display":"14,176.80","total_whole":"14,177","shares_owned_after":1484.0,"shares_owned_after_display":"1,484","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-27","scope":"insider"},{"id":6256417,"accession":"0001610618-22-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-22-000078","line_url":"/filing/0001610618-22-000078#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18159.0,"shares_display":"18,159","price_per_share":0.6849,"price_display":"0.68","price_state":"stated","total_value":12437.0991,"total_display":"12,437.10","total_whole":"12,437","shares_owned_after":193741.0,"shares_owned_after_display":"193,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6946542,"accession":"0001209191-22-002600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002600","line_url":"/filing/0001209191-22-002600#line-2","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001870270","owner_name":"Tari Leslie","owner_display_name":"Tari Leslie","owner_url":"/insider/0001870270","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":1565.0,"total_display":"1,565.00","total_whole":"1,565","shares_owned_after":155400.0,"shares_owned_after_display":"155,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610618","name":"Cidara Therapeutics, Inc.","url":"/issuer/0001610618","role":"Officer (CHIEF SCIENTIFIC OFFICER)","n_filings":9,"first_seen":"2022-01-07","last_seen":"2025-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001870270","retrieved_at":"2026-08-24T00:16:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}